trial · primary record
OC-CTLs
Ovarian Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Safety of OC-CTLs in patients using CTCAE version 4.0 standard to evaluate the level of adverse events |
| Registry ID | NCT03362606 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:59:03.293Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03362606
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.